Evaluation of the Medical and Surgical Treatment of Chronic Rhinosinusitis: A Prospective, Randomised, Controlled Trial

Laryngoscope

Volumn 114, Issue 5, 2004, Pages 923-930

  Ragab, Sameh M ^a   Lund, Valerie J ^b   Scadding, Glenis ^c  

^a TANTA UNIVERSITY HOSPITAL   (Egypt)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

Author keywords

Chronic rhinosinusitis; Endoscopic sinus surgery; Medical treatment; Nasal polyposis; Nitric oxide; Randomized; SF 36; SNOT 20; Surgical treatment; Visual analogue score

Indexed keywords

ALKALI; CORTICOSTEROID; DEXAMETHASONE ISONICOTINATE; DEXARHINASPRAY; ERYTHROMYCIN; FLUTICASONE PROPIONATE; MACROLIDE; NASAL DOUCHE AGENT; NITRIC OXIDE; PREDNISOLONE; STEROID; TRAMAZOLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC RHINITIS; CHRONIC SINUSITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC SURGERY; ENDOSCOPY; EPISTAXIS; FEMALE; HEALTH SURVEY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NASAL ENDOSCOPY; NAUSEA; NOSE POLYP; PARAMETER; PARANASAL SINUS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RHINOMETRY; RHINOSINUSITIS; SACCHARINE CLEARANCE TEST; SHORT FORM 36; SINONASAL OUTCOME TEST 20; VISUAL ANALOG SCALE;

EID: 2442475516     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200405000-00027     Document Type: Article

References (57)

1. Melen I. Chronic sinusitis: clinical and pathophysiological aspects. Acta Otolaryngol 1994;515:45-48.
2. Hamilos DL. Chronic sinusitis. J Allergy Clinic Immunol 2000;106:213-227.
3. Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998;124:513-518.
4. Keith P, Nieminen J, Hollingworth K, Dolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000;30:1460-1468.
5. Penttila M, Poulsen P, Hollingworth K, Holmstrom M. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy 2000;30:94-102.
6. Stammberger H. Results, problems and complications. In: Stammberger H, ed. Functional Endoscopic Sinus Surgery. The Messerklinger Technique. Philadelphia: BC Decker, 1991;459-477.
7. Lund VJ, Mackay IS. Outcome assessment of endoscopic sinus surgery. J R Soc Med 1994;87:70-72.
8. Senior BA, Kennedy DW, Tanabodee J, Lanza D, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998;108:151-157.
9. Waguespack R. Mucociliary clearance patterns following endoscopic sinus surgery. Laryngoscope 1995;105:1-40.
10. Lund VJ, Scadding GK. Objective assessment of endoscopic sinus surgery in the management of chronic rhinosinusitis: ah update. J Laryngol Otol 1994;108:749-753.
11. Abdel-Hak B, Gunkel A, Kanonier G, et al. Ciliary beat frequency, olfaction and endoscopic sinus surgery. ORL J Otorhinolaryngol Relat Spec 1998;60:202-205.
12. Stammberger H, Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol Suppl 1988;134:3-23.
13. Stankiewicz JA. Complications in endoscopic intranasal ethmoidectomy: an update. Laryngoscope 1989;99:686-690.
14. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl 1995;167:17-21.
15. Leopold D, Ferguson BJ, Piccirillo JF. Outcomes assessment. Otolaryngol Head Neck Surg 1997;117:S58-S68.
16. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
17. Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology 1993;31:183-184.
18. Mackay IS, Lund VJ. Imaging and staging. In: Mygind N, Lildholdt T, eds. Nasal Polyposis. An Inflammatory Disease and Its Treatment. Copenhagen: Munksgaard, 1997;137-144.
19. Stammberger H. Surgical technique. In: Stammberger H, ed. Functional Endoscopic Sinus surgery. The Messerklinger Technique. Philadelphia: BC Decker, 1991;283-320.
20. Lildholdt T, Fogstrup J, Gammelgaard N, et al. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol 1988;105:140-143.
21. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997;123:595-600.
22. Blomqvist EH, Lundblad L, Anggard A, et al. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001;107:224-228.
23. Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg 1997;117:12-17.
24. Winstead W, Barnett SN. Impact of endoscopic sinus surgery on global health perception: an outcomes study. Otolaryngol Head Neck Surg 1998;119:486-491.
25. Jones ML, Piccirillo JF, Haiduk A, Thawley SE. Functional endoscopic sinus surgery: do ratings of appropriateness predict patient outcomes? Am J Rhinol 1998;12:249-255.
26. Damm M, Quante G, Jungehuelsing M, Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope 2002;112:310-315.
27. Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996;525:73-78.
28. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996;23:48-56.
29. Kimura N, Nishioka K, Nishizaki K, et al. Clinical effect of low-dose, long-term roxithromycin chemotherapy in patients with chronic sinusitis. Acta Med Okayama 1997;51:33-37.
30. Yamada T, Fujieda S, Mori S, et al. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000;14:143-148.
31. Williams JD, Sefton AM. Comparison of macrolide antibiotics. J Antimicrob Chemother 1993;31:11-26.
32. Zhanel GG, Dueck M, Hoban DJ, et al. Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 2001;61:443-498.
33. Sofer D, Gilboa-Garber N, Belz A, Garber NC. "Subinhibitory" erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 1999;45:335-341.
34. Ozeki M, Miyamoto N, Hashiba M, Baba S. Inhibitory effect of roxithromycin on biofilm formation of Pseudomonas aeruginosa. Acta Otolaryngol Suppl 1996;525:61-63.
35. Konno S, Adachi M, Asano K, et al. Influences of roxithromycin on cell-mediated immune responses. Life Sci 1992;51: L107-L112.
36. Takizawa H, Desaki M, Ohtoshi T, et al. Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. Eur Respir J 1998;12:57-63.
37. Tamaoki J, Kondo M, Kohri K, et al. Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages. J Immunol 1999;163:2909-2915.
38. Aoki Y, Kao PN. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrob Agents Chemother 1999;43:2678-2684.
39. Abe S, Nakamura H, Inoue S, et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2000;22:51-60.
40. Miyanohara T, Ushikai M, Matsune S, et al. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000;110:126-131.
41. Anderson R, Theron AJ, Feldman C. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation 1996;20:693-705.
42. Aoshiba K, Nagai A, Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 1995;39:872-877.
43. Sato E, Nelson DK, Koyama S, et al. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro. Antimicrob Agents Chemother 2001;45:401-406.
44. Keicho N, Kudoh S, Yotsumoto H, Akagawa KS. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J Antibiot (Tokyo) 1993;46:1406-1413.
45. Sugiura Y, Ohashi Y, Nakai Y. Roxythromycin stimulates the mucociliary activity of the Eustachian tube and modulates neutrophil activity in the healthy guinea pig. Acta Otolaryngol Suppl 1997;531:34-38.
46. Nakano T, Ohashi Y, Tanaka A, et al. Roxythromycin reinforces epithelial defence function in rabbit trachea. Acta Otolaryngol Suppl 1998;538:233-238.
47. LaForce CF, Szefler SJ, Miller MF, et al. Inhibition of methylprednisolone elimination in the presence of erythromycin therapy. J Allergy Clin Immunol 1983;72:34-39.
48. Spahn JD, Fost DA, Covar R, et al. Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann Allergy Asthma Immunol 2001;87:501-505.
49. Sykes DA, Wilson R, Chau KL, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet 1986;2:359-360.
50. Cuenant G, Stipon JP, Plante-Longchamp G, Baudoin C, Guerrier Y. Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORL J Otorhinolaryngol Relat Spec 1986;48:226-232.
51. Qvarnberg Y, Kantola O, Salo J, et al. Influence of topical steroid treatment on maxillary sinusitis. Rhinology 1992;30:103-112.
52. Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001;39:75-79.
53. Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J Pharm Pharmacol 1985;37:294-297.
54. Lund VJ. Diagnosis and treatment of nasal polyps. BMJ 1995;311:1411-1414.
55. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992;102(Suppl 57):1-18.
56. King JM, Caldarelli DD, Pigato JB. A review of revision functional endoscopic sinus surgery. Laryngoscope 1994;104:404-408.
57. Sobol SE, Wright ED, Frenkiel S. One-year outcome analysis of functional endoscopic sinus surgery for chronic sinusitis. J Otolaryngol 1998;27:252-257.